The purpose of our investigation was to evaluate, in colon cancer and glioblastoma cell lines, whether HIPK2 might inhibit HIF-1α expression and activity in hypoxia-mimicking condition and sensitize chemoresistant tumor cells to adriamycin (ADR)-induced apoptosis. Here, HIPK2 is linked to glioblastoma.